tirzepatide heart failure for in Patients with Obesity Tirzepatide for Heart Failure Shows

and Jessica O

Semaglutide, Dulaglutide, Liraglutide, and Tirzepatide dominate the GLP-1 agonist market

In line with above findings, our results showed that a lower GLP-1 signaling score was related to a better clinical outcome in patients with urothelial carcinoma and non-small cell lung cancer after immunotherapeutic treatment

Sample sections were blocked in 5 % goat serum with 0.3 % Triton X-100 for 1 h at RT and then incubated overnight at 4 C with the following primary antibodies: mouse anti-GLP-1R (1:50, Santa Cruz, CA, USA), mouse anti-GLP-1(1:50, Santa Cruz, CA, USA), rabbit anti-Iba1 (1:500, Wako Chemicals, Tokyo, Japan), rabbit anti-GFAP (1:200, Cell Signalling, Boston, MA, USA), rabbit anti-NeuN (1:100, Proteintech, China), mouse anti-CGRP (1:100, Santa Cruz, CA, USA), and mouse anti-c-fos (1:100, Santa Cruz, CA, USA)